Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-15-086171

Chief Financial Officer bought 10,000 shares at $2.00 ($20,000)

From the SEC's structured data for this filing

Trades in this filing

Payne Fletcher · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-12-17 Purchase : show line 1 in the form +10,000 $2.00 $20,000 25,032 I
Open-market purchases · 10,000 sh · avg $2.00 · $20,000
Loading xslF345X03/doc4.xml…